{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cardiovascular", "hypertension", "lipids", "pharmacodynamics", "traditional medicine Africa"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "32725873", "DateCompleted": {"Year": "2021", "Month": "01", "Day": "27"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "29"}], "Language": ["eng"], "ELocationID": ["10.1002/ptr.6792"], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "34", "Issue": "12", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts (NW Roselle): A phase-II, randomized, double-blind, captopril-controlled clinical trial.", "Pagination": {"StartPage": "3379", "EndPage": "3387", "MedlinePgn": "3379-3387"}, "Abstract": {"AbstractText": ["Hypertension is a public health concern that needs immediate attention upon diagnosis. The demand for natural alternatives is on the rise; Hibiscus sabdariffa and Olea europaea are traditionally used for hypertension management in Egypt. In this study, we aimed to investigate the antihypertensive efficacy and safety of two doses of an herbal product of Hibiscus sabdariffa calyxes and Olea europaea leaves (NW Roselle) in Egyptian patients with grade 1 essential hypertension. We equally randomized 134 patients to receive captopril 25\u2009mg, low-dose NW Roselle, or high-dose NW Roselle BID for 8\u2009weeks. No significant decrease was found in systolic blood pressure or diastolic blood pressure when we compared low-dose NW Roselle and high-dose NW Roselle to captopril (p >\u2009.05). In all groups, mean reduction in BP at 8\u2009weeks was significant; 16.4/9.9\u2009mmHg (p <\u2009.0001), 15.4/9.6\u2009mmHg (p <\u2009.0001), and 14.9/9.4\u2009mmHg (p <\u2009.0001) with captopril, low-dose NW Roselle, and high-dose NW Roselle respectively. In addition, low-dose NW Roselle induced a significant reduction in the mean level of triglycerides (17.56\u2009mg/dL; p =\u2009.038). In conclusion, NW Roselle had comparable antihypertensive efficacy and safety to captopril in Egyptian patients with grade 1 essential hypertension."], "CopyrightInformation": "\u00a9 2020 John Wiley & Sons, Ltd."}, "AuthorList": [{"Identifier": ["0000-0002-7579-7515"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Internal Medicine and Diabetology, Faculty of Medicine, Menoufia University, Menoufia, Egypt."}], "LastName": "Elkafrawy", "ForeName": "Nabil", "Initials": "N"}, {"Identifier": ["0000-0001-5024-0350"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Internal Medicine Department, Medical Division, National Research Centre, Giza, Egypt."}], "LastName": "Younes", "ForeName": "Khaled", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Cardiology and Angiology, Alexandria University, Alexandria, Egypt."}], "LastName": "Naguib", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Internal Medicine, Diabetes and Endocrinology, Menoufia University, Menoufia, Egypt."}], "LastName": "Badr", "ForeName": "Hytham", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Internal Medicine, Diabetes and Endocrinology, Menoufia University, Menoufia, Egypt."}], "LastName": "Kamal Zewain", "ForeName": "Shimaa", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Internal Medicine, Diabetes and Endocrinology, Menoufia University, Menoufia, Egypt."}], "LastName": "Kamel", "ForeName": "Mai", "Initials": "M"}, {"Identifier": ["0000-0002-8021-5460"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Department, Pharmaceutical and Drug Research Industries Division, National Research Centre, Giza, Egypt."}], "LastName": "Raoof", "ForeName": "Gehan Fawzy Abdel", "Initials": "GFA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt."}], "LastName": "M El-Desoky", "ForeName": "Ahmed", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor, Malaysia."}], "LastName": "Mohamed", "ForeName": "Shanaz", "Initials": "S"}], "PublicationTypeList": ["Clinical Trial, Phase II", "Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "9G64RSX1XD", "NameOfSubstance": "Captopril"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Captopril"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hibiscus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Hypertension"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["chemistry"], "DescriptorName": "Olea"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ali, B. H., Al Wabel, N., & Blunden, G. (2005). Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: A review. Phytotherapy Research, 19(5), 369-375. https://doi.org/10.1002/ptr.1628"}, {"Citation": "Alwan, A., Armstrong, T., & Cowan, M. R. L. (2011). Non communicable diseases country profiles 2011 (pp. 1-207). Geneva, Switzerland: World Health Organization. https://doi.org/10.2471/BLT.07.045138"}, {"Citation": "Alwan, A., MacLean, D. R., Riley, L. M., D'Espaignet, E. T., Mathers, C. D., Stevens, G. A., & Bettcher, D. (2010). Monitoring and surveillance of chronic non-communicable diseases: Progress and capacity in high-burden countries. The Lancet, 376(9755), 1861-1868. https://doi.org/10.1016/S0140-6736(10)61853-3"}, {"Citation": "Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002). The treatment of hypertension in adult patients with diabetes. Diabetes Care, 25(1), 134-147. https://doi.org/10.2337/diacare.25.1.134"}, {"Citation": "Asgary, S., Soltani, R., Zolghadr, M., Keshvari, M., & Sarrafzadegan, N. (2016). Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: A double-blind placebo-controlled clinical trial. Journal of Complementary and Integrative Medicine, 13(2), 175-180. https://doi.org/10.1515/jcim-2015-0030"}, {"Citation": "Bennani-Kabchi, N., Fdhil, H., & Cherrah, Y. (1999). Effects of Olea europea var. oleaster leaves in hypercholesterolemic insulin-resistant sand rats. Th\u00e9rapie, 54(6), 717-723. Retrieved from http://europepmc.org/article/med/10709446"}, {"Citation": "Cherif, S., Rahal, N., Haouala, M., Hizaoui, B., & Dargouth, F. (1996). A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension. Journal de Pharmacie de Belgique, 51(2), 69-71. Retrieved from http://europepmc.org/article/med/8786521"}, {"Citation": "Engels, G. (2007). Herb profile: Hibiscus. The Journal of the American Botanical Council, 74, 1-6. Retrieved from http://cms.herbalgram.org/herbalgram/issue74/article3102.html?ts=1579614291&signature=05880916465417a773fbe0640db35dc8"}, {"Citation": "Haji Faraji, M., & Haji Tarkhani, A. H. (1999). The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. Journal of Ethnopharmacology, 65(3), 231-236. http://dx.doi.org/10.1016/s0378-8741(98)00157-3."}, {"Citation": "Hansen, K., Adsersen, A., Christensen, S. B., Jensen, S. R., Nyman, U., & Smitt, U. W. (1996). Isolation of an angiotensin converting enzyme (ACE) inhibitor from Olea europaea and Olea lancea. Phytomedicine, 2(4), 319-325. https://doi.org/10.1016/S0944-7113(96)80076-6"}, {"Citation": "Herrera-Arellano, A., Flores-Romero, S., Ch\u00e1vez-Soto, M. A., & Tortoriello, J. (2004). Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: A controlled and randomized clinical trial. Phytomedicine, 11(5), 375-382. https://doi.org/10.1016/j.phymed.2004.04.001"}, {"Citation": "Herrera-Arellano, A., Miranda-S\u00e1nchez, J., \u00c1vila-Castro, P., Herrera-\u00c1lvarez, S., Jim\u00e9nez-Ferrer, J. E., Zamilpa, A., \u2026 Tortoriello, J. (2007). Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Medica, 73(1), 6-12. https://doi.org/10.1055/s-2006-957065"}, {"Citation": "Ibrahim, M. M., Rizk, H., Appel, L. J., El Aroussy, W., Helmy, S., Sharaf, Y., \u2026 Whelton, P. K. (1995). Hypertension prevalence, awareness, treatment, and control in Egypt. Hypertension, 26(6), 886-890. https://doi.org/10.1161/01.HYP.26.6.886"}, {"Citation": "Ibrahim, M. M. (2014). The Egyptian hypertension society. The Egyptian Heart Journal, 66(2), 79-132. https://doi.org/10.1016/j.ehj.2014.03.001"}, {"Citation": "Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005). Global burden of hypertension: Analysis of worldwide data. The Lancet, 365(9455), 217-223. https://doi.org/10.1016/s0140-6736(05)17741-1"}, {"Citation": "Lijnen, P., Staessen, J., Fagard, R., & Amery, A. (1982). Increase in plasma aldosterone during prolonged captopril treatment. The American Journal of Cardiology, 49(6), 1561-1563. https://doi.org/10.1016/0002-9149(82)90390-3"}, {"Citation": "Lockyer, S., Rowland, I., Spencer, J. P. E., Yaqoob, P., & Stonehouse, W. (2017). Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: A randomised controlled trial. European Journal of Nutrition, 56(4), 1421-1432. https://doi.org/10.1007/s00394-016-1188-y"}, {"Citation": "Masoko, P., Picard, J., & Eloff, J. N. (2005). Antifungal activities of six South African Terminalia species (Combretaceae). Journal of Ethnopharmacology, 99(2), 301-308. http://dx.doi.org/10.1016/j.jep.2005.01.061."}, {"Citation": "McKay, D. L., Chen, C.-Y. O., Saltzman, E., & Blumberg, J. B. (2010). Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. The Journal of Nutrition, 140(2), 298-303. https://doi.org/10.3945/jn.109.115097"}, {"Citation": "Mozaffari-Khosravi, H., Jalali-Khanabadi, B.-A., Afkhami-Ardekani, M., Fatehi, F., & Noori-Shadkam, M. (2009). The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. Journal of Human Hypertension, 23(1), 48-54. https://doi.org/10.1038/jhh.2008.100"}, {"Citation": "Perrinjaquet-Moccetti, T., Busjahn, A., Schmidlin, C., Schmidt, A., Bradl, B., & Aydogan, C. (2008). Food supplementation with an olive (Olea europaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytotherapy Research, 22(9), 1239-1242. https://doi.org/10.1002/ptr.2455"}, {"Citation": "Pizzorno, J. E., Murray, M. T., & Joiner-Bey, H. (2016). Hypertension. In The Clinician's handbook of natural medicine (3rd Ed., pp. 408-420). Amsterdam, Netherlands: Elsevier. https://doi.org/10.1016/B978-0-7020-5514-0.00045-2"}, {"Citation": "Seck, S. M., Doupa, D., Dia, D. G., Diop, E. A., Ardiet, D.-L., Nogueira, R. C., \u2026 Diouf, B. (2018). Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa. Journal of Human Hypertension, 32(1), 75-81. https://doi.org/10.1038/s41371-017-0001-6"}, {"Citation": "Serban, C., Sahebkar, A., Ursoniu, S., Andrica, F., & Banach, M. (2015). Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. Journal of Hypertension, 33(6), 1119-1127. https://doi.org/10.1097/HJH.0000000000000585"}, {"Citation": "Sindi, H. A., Marshall, L. J., & Morgan, M. R. A. (2014). Comparative chemical and biochemical analysis of extracts of Hibiscus sabdariffa. Food Chemistry, 164, 23-29. https://doi.org/10.1016/j.foodchem.2014.04.097"}, {"Citation": "Sowers, J., Epstein, M., & Frohlich, E. (2001). Diabetes, hypertension, and cardiovascular disease: An update. Hypertension, 37(3), 1053-1059. https://doi.org/10.1161/01.HYP.38.3.e11"}, {"Citation": "Susalit, E., Agus, N., Effendi, I., Tjandrawinata, R. R., Nofiarny, D., Perrinjaquet-Moccetti, T., & Verbruggen, M. (2011). Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with captopril. Phytomedicine, 18(4), 251-258. https://doi.org/10.1016/j.phymed.2010.08.016"}, {"Citation": "V\u00e4\u00e4r\u00e4niemi, K., Koskela, J., Tahvanainen, A., Tikkakoski, A., Wilenius, M., K\u00e4h\u00f6nen, M., \u2026 P\u00f6rsti, I. (2014). Lower glomerular filtration rate is associated with higher systemic vascular resistance in patients without prevalent kidney disease. The Journal of Clinical Hypertension, 16(10), 722-728. https://doi.org/10.1111/jch.12405"}, {"Citation": "Wahabi, H. A., Alansary, L. A., Al-Sabban, A. H., & Glasziuo, P. (2010). The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: A systematic review. Phytomedicine, 17(2), 83-86. https://doi.org/10.1016/j.phymed.2009.09.002"}, {"Citation": "Williams, B., Mancia, G., Spiering, W., Rosei, E., Azizi, M., Burnier, M., \u2026 Zanchetti, A. (2018). 2018 ESC/ESH guidelines for the management of artterial hypertension. The task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertenion (ESH). European Heart Journal, 39, 3021-3104. https://doi.org/10.1093/eurheartj/ehy339"}, {"Citation": "World Health Organization. (2002). WHO traditional medicine strategy 2002-2005 (pp. 1-74). Geneva, Switzerland: World Health Organization WHO/EDM/TRM/2002.1. https://doi.org/WHO/EDM/TRM/2002.1."}, {"Citation": "World Health Organization. (2020). Hypertension. Retrieved from https://www.who.int/health-topics/hypertension/#tab=tab_1"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "3", "Day": "8"}, {"Year": "2020", "Month": "5", "Day": "23"}, {"Year": "2020", "Month": "6", "Day": "13"}, {"Year": "2020", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32725873", "10.1002/ptr.6792"]}}], "PubmedBookArticle": []}